Obstetric risk factors and persistent increases in brain parenchymal echogenicity in preterm infants

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 111, Issue 9, 2004, Pages 913-918

  Spinillo, Arsenio ^a   Chiara, Alberto ^b   Bergante, Carola ^a   Biancheri, Danila ^a   Fabiana, DePaoli ^a   Fazzi, Elisa ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; DEXAMETHASONE; STEROID;

ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; DEGENERATION; ECHOGRAPHY; HUMAN; INFANT; INFORMATION PROCESSING; INTRAUTERINE GROWTH RETARDATION; ITALY; LOGISTIC REGRESSION ANALYSIS; MEDICAL ASSESSMENT; OBSTETRICS; PARENCHYMA; PREECLAMPSIA; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

BRAIN DISEASES; ECHOENCEPHALOGRAPHY; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; MATERNAL AGE; MATERNAL EXPOSURE; PREGNANCY; PREGNANCY COMPLICATIONS; STEROIDS;

EID: 4544364117     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2004.00229.x     Document Type: Article

References (25)

1. De Vries LS. Neurological assessment of the preterm infant. Acta Paediatr 1996;85:765-771.
2. Volpe JJ. Neurobiology of periventricular leukomalacia in premature infant. Pediatr Res 2001;50:553-662.
3. Ment LR, Vohr B, Allan W. Outcome of children in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics 2000;105:485-491.
4. Adams DF, Ment LR, Vohr B. Antenatal therapies and the developing brain. Semin Neonatal 2001;6:173-183.
5. Kubota H, Ohsone Y, Oka F, Sueyoshi T, Takanashi J, Kohno Y. Significance of clinical risk factors of cystic periventricular leukomalacia in infants of different birthweights. Acta Paediatr 2001;90:302-308.
6. Davey DA, McGillivray IM. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988;158:892-898.
7. MacDonald D, Grant A, Sheridan-Pereira M, Boylan P, Chalmers I. The Dublin randomized controlled trial of intrapartum fetal heart rate monitoring. Am J Obstet Gynecol 1985;152:524-539.
8. Gibbs RS, Duff P. Progress in pathogenesis and management of clinical intraamniotic infection. Am J Obstet Gynecol 1991;164:1317-1326.
9. Papile L, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weight less than 1500 gm. J Pediatr 1978;92:529-534.
10. Amiel-Tison C, Grenier A. Evaluation neurologique du nouveau-ne et du nourisson. Masson-Paris, 1980.
11. De Vries LS, Dubowitz V, Lary S. Predictive value of cranial ultrasound in the newborn baby: a reappraisal. Lancet 1985;ii:137-140.
12. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: Wiley, 1989;86:720-724.
13. Koopman JS. Interaction between discrete causes. Am J Epidemiol 1981;113:716-724.
14. Weindling M. Periventricular hemorrhage and periventricular leukomalacia. Br J Obstet Gynaecol 1995;102:278-281.
15. Ringelberg J, Van-de-bor M. Outcome of transient periventricular echodensities in preterm infants. Neuropediatrics 1993;24:269-273.
16. Damman O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997;42:1-8.
17. Spinillo A, Capuzzo E, Stronati M, Ometto A, De Santolo A, Acciano S. Obstetric risk factors for periventricular leukomalacia among preterm infants. Br J Obstet Gynaecol 1998;105:865-871.
18. Baud O, Foix-L'Helias L, Kaminski M, et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very prema-ture infants. N Engl J Med 1999;341(16):1190-1196.
19. Canterino JC, Verma U, Visintainer PF, Elimian A, Klein SA, Tejani N. Antenatal steroids and neonatal periventricular leukomalacia. Obstet Gynecol 2001;97:135-139.
20. Thebaud B, Lacaze-Masmonteil T, Watterberg K. Postnatal glucocorticoids in very preterm infants: 'the good, the bad, the ugly'? Pediatrics 2001;107:413-415.
21. Jazayeri A, Gavrila D, Sincich T. Repeated antenatal corticosteroid treatments. Do they reduce neonatal morbidity? J Reprod Med 2001; 46(9):788-790.
22. Walfisch A, Hallak M, Mazor M. Multiple courses of antenatal steroids: risks and benefits. Obstet Gynecol 2001;98:491-497.
23. Whitelaw A, Thoresen M. Antenatal steroids and the developing brain. Arch Dis Child 2000;83:F154-F157.
24. Modi N, Lewis H, Al-Naqeeb N, Ajayi-Obe M, Dore CJ, Rutherford M. The effects of repeated antenatal glucocorticoid therapy on the developing. Pediatr Res 2001;50(5):581-585.
25. Guinn DA, Atkinson MW, Sullivan L, et al. Single vs. weekly courses of antenatal corticosteroids for women at risk of preterm delivery: A randomized controlled trial. JAMA 2001;286(13):1581-1587.